Capricor Therapeutics Inc (CAPR)
17.79
-1.13
(-5.97%)
USD |
NASDAQ |
Nov 21, 16:00
17.76
-0.02
(-0.14%)
After-Hours: 20:00
Capricor Therapeutics Enterprise Value: 723.88M for Nov. 21, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 21, 2024 | 723.88M |
| November 20, 2024 | 775.26M |
| November 19, 2024 | 754.35M |
| November 18, 2024 | 750.71M |
| November 15, 2024 | 761.17M |
| November 14, 2024 | 755.71M |
| November 13, 2024 | 683.87M |
| November 12, 2024 | 736.82M |
| November 11, 2024 | 802.21M |
| November 08, 2024 | 809.47M |
| November 07, 2024 | 770.88M |
| November 06, 2024 | 742.73M |
| November 05, 2024 | 752.72M |
| November 04, 2024 | 759.30M |
| November 01, 2024 | 798.12M |
| October 31, 2024 | 827.64M |
| October 30, 2024 | 884.85M |
| October 29, 2024 | 913.45M |
| October 28, 2024 | 889.39M |
| October 25, 2024 | 903.92M |
| October 24, 2024 | 878.04M |
| October 23, 2024 | 886.21M |
| October 22, 2024 | 829.45M |
| October 21, 2024 | 848.98M |
| October 18, 2024 | 771.33M |
| Date | Value |
|---|---|
| October 17, 2024 | 660.72M |
| October 16, 2024 | 742.19M |
| October 15, 2024 | 786.15M |
| October 14, 2024 | 704.68M |
| October 11, 2024 | 631.68M |
| October 10, 2024 | 606.27M |
| October 09, 2024 | 613.13M |
| October 08, 2024 | 694.60M |
| October 07, 2024 | 644.58M |
| October 04, 2024 | 788.17M |
| October 03, 2024 | 603.45M |
| October 02, 2024 | 581.26M |
| October 01, 2024 | 520.36M |
| September 30, 2024 | 528.43M |
| September 27, 2024 | 322.15M |
| September 26, 2024 | 323.56M |
| September 25, 2024 | 335.93M |
| September 24, 2024 | 292.11M |
| September 23, 2024 | 181.50M |
| September 20, 2024 | 148.99M |
| September 19, 2024 | 146.87M |
| September 18, 2024 | 151.47M |
| September 17, 2024 | 150.05M |
| September 16, 2024 | 126.38M |
| September 13, 2024 | 119.89M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-4.972M
Minimum
Mar 10 2020
913.45M
Maximum
Oct 29 2024
90.37M
Average
65.85M
Median
Jan 30 2023
Enterprise Value Benchmarks
| Abbott Laboratories | 210.81B |
| ICU Medical Inc | 5.416B |
| ResMed Inc | 36.01B |
| enVVeno Medical Corp | 9.490M |
| AIM ImmunoTech Inc | 9.017M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -12.56M |
| Revenue (Quarterly) | 2.262M |
| Total Expenses (Quarterly) | 15.27M |
| EPS Diluted (Quarterly) | -0.38 |
| Profit Margin (Quarterly) | -555.2% |
| Earnings Yield | -5.73% |
| Normalized Earnings Yield | -6.082 |